Remedy Pharmaceuticals Secures $500,000 New Financing

  • Feed Type
  • Date
    11/22/2011
  • Company Name
    Remedy Pharmaceuticals
  • Mailing Address
    Undisclosed New York, NY 10001
  • Company Description
    Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
  • Website
    http://www.remedypharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing – amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.